Skip to main content
Ad Scientiam
Back to previous page
Blog post

Key figures 2021

March 29, 2022

Ad Scientiam, leader in digital biomarkers, continues its strong growth. A look back at the highlights of 2021 in figures.

Ad Scientiam, leader in digital biomarkers, continues its strong growth and 2021 was a particularly rich year for us.

A look back at the highlights of 2021 in figures.

Share this news with your network

Accelerate your clinical studies and improve the monitoring of your patients

Talk to our experts and discover how our solutions integrate into your practice or studies.

Ad Scientiam

Digital Village, 21-23 Rue Albert Bayet, 75013 Paris

contact@adscientiam.com

About us

Our Solutions

Contact us

Our news